✦ LIBER ✦

HIV-1 fusion mechanism could be target for new drugs

✍ Scribed by Kelly Morris

Book ID: 119503492
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 29 KB
Volume: 349
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)62424-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FC1 lignanolides as potent inhibitors of

FC1 lignanolides as potent inhibitors of HIV-1 integrase, a new target for drug development

✍ Eich, E.; Pertz, H.; Kaloga, M.; Schulz, J.; Fesen, M.R.; Mazumder, A.; Pommier, 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Restrained molecular dynamics simulation

Restrained molecular dynamics simulations of HIV-1 protease: The first step in validating a new target for drug design

✍ Alexander L. Perryman; Jung-Hsin Lin; J. Andrew McCammon 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 804 KB

## Abstract To test the anticorrelated relationship that was recently displayed in conventional molecular dynamics (MD) simulations, several different restrained MD simulations on a wild type and on the V82F/I84V drug‐resistant mutant of HIV‐1 protease were performed. This anticorrelated relationsh

Cell membranes, cell fusion and phosphol

Cell membranes, cell fusion and phospholipids: New targets and novel inhibitors of HIV-1 : D. Kinchington1, T. O'Connor1, S. Galpin1, B. Swords2 and C. McGuigan2. 1 Department of Virology, Medical College of St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. 2 Department of Chemistry, University of Southampton, Highfield, Southampton, SO9 5NH, UK.

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 73 KB